Malaysia Cardiovascular Devices Market to to Grow with a CAGR of 5.90% through 2030
A surge in consumption of
unhealthy diet is expected to drive the growth of the Malaysia cardiovascular
devices market in the forecast period, 2026-2030.
According to TechSci Research report, “Malaysia
Cardiovascular Devices Market – Industry Size, Share, Trends, Competition, Opportunities and
Forecast, 2030F”, the Malaysia cardiovascular devices market stood at USD 4.14 billion in 2024 and is anticipated to grow with a CAGR of 5.90% in the forecast period through 2030. This
can be ascribed to the growing demand for the accurate diagnosis of the
disease. In Malaysia, the demand for cardiovascular devices has increased
because of the rise in the burden of cardiovascular illnesses and the
requirement for early diagnosis. The introduction of precise equipment to treat
such diseases and the availability of a wide range of treatment options for
patients have both been made possible by advancements in diagnosis and
treatment options, which have also sparked a better understanding of the
different forms of cardiovascular diseases. The market for cardiovascular
devices is likely to develop because of this trend throughout the forecast
period. Furthermore, electrocardiograms (ECGs) are also increasingly being used
in Malaysia for diagnostic and monitoring purposes, and they are particularly
well-liked in the home healthcare industry. To assist identify and track
disorders affecting the heart, an ECG is frequently used in conjunction with
other testing. Additionally, there are several upcoming wearable ECG
monitoring systems that can wirelessly record ECG and heart rate. The use of
ECG has increased because of a rise in product launches and approvals. During
the forecast period, this trend is also anticipated to persist, fuelling market
expansion.
The cardiovascular devices market in Malaysia has
seen a notable growth over the last few years, but it is not without its
challenges. One of the primary challenges facing the Malaysia
cardiovascular devices market is limited government funding. The government
funding for healthcare is limited, and most of the funds are allocated to
primary healthcare services, leaving little to no funding for the
cardiovascular devices market. This can make it difficult for manufacturers to
introduce new devices into the market, as they may not have access to the
necessary resources to support their product development and marketing efforts.
Another challenge faced by the Malaysia cardiovascular devices market is a lack
of skilled professionals. There are a limited number of healthcare
professionals trained in cardiovascular care, including doctors, nurses, and technicians.
This can create a bottleneck in the healthcare system, as there may not be
enough skilled professionals to meet the demand for cardiovascular care. It can
also make it difficult for manufacturers to find skilled professionals to train
on their products. Finally, the Malaysia cardiovascular devices market is
highly competitive, with many established players already present in the
market. This can make it difficult for new entrants to gain a foothold and
compete effectively. Established players have an advantage in terms of brand
recognition, distribution networks, and customer loyalty, which can make it
challenging for new players to establish a presence in the market.
Malaysia
cardiovascular devices market can be segmented by type, application, end user,
source, and region.
Based on Type, Surgical devices, including pacemakers, stents, defibrillators, and prosthetic valves, are witnessing the fastest growth. This is driven by advancements in surgical techniques, the increasing availability of minimally invasive procedures, and expanding healthcare infrastructure in both urban and semi-urban areas. Malaysia’s aging population and rising rates of complex cardiovascular diseases are creating a growing need for interventional procedures that require sophisticated surgical equipment. Public and private hospitals are increasingly investing in advanced surgical technology to offer more effective and efficient cardiac treatments, particularly in West Malaysia where tertiary care centers are more concentrated. As access to specialized cardiac care improves in East Malaysia as well, the demand for surgical devices is expected to grow at an even faster pace.
Based on Region, East Malaysia which includes the states of Sabah and Sarawak is witnessing significant growth. This upward trend can largely be attributed to ongoing efforts to improve healthcare accessibility and infrastructure in the region. Traditionally, much of Malaysia's advanced medical infrastructure has been concentrated in West Malaysia, but in recent years, the federal and state governments have made notable strides in expanding specialized healthcare services to the eastern part of the country. New cardiac care centers and public health investments are enhancing the availability of cardiovascular diagnostics and treatments in East Malaysia. These initiatives aim to reduce the need for patients to travel long distances to the Peninsula for procedures like angioplasty or cardiac surgeries. With the addition of skilled medical personnel, improved facilities, and modern diagnostic equipment, healthcare institutions in East Malaysia are becoming increasingly equipped to meet the demands of a growing and aging population that is at risk for heart-related conditions.
Major companies operating in
Malaysia cardiovascular devices market are:
- B. Braun Medical Supplies Sdn Bhd
- Abbott Medical Malaysia Sdn Bhd
- LivaNova Malaysia SDN BHD
- Edwards Lifesciences (M) Sdn Bhd
- GE Healthcare
- BIOTRONIK Medical Devices (Malaysia) SDN BHD
- Terumo Malaysia Sdn. Bhd.
- FUJIFILM Malaysia Sdn. Bhd.
- Philips Malaysia Sdn Bhd
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“The
cardiovascular devices market in Malaysia is poised for growth in the coming
years, driven by technological advancements and an increasing demand for
minimally invasive procedures. For example, remote patient monitoring is an
emerging trend in the cardiovascular devices market, allowing healthcare
providers to monitor patients outside of a traditional clinical setting. This
technology is particularly useful for patients with chronic conditions, such as
heart failure or arrhythmia, allowing them to receive regular monitoring
without the need for frequent clinic visits. Remote monitoring can also help
identify potential issues early, allowing for timely intervention and
potentially preventing hospitalizations. Moreover, minimally invasive
procedures are becoming increasingly popular in the cardiovascular devices
market, reducing the need for traditional open-heart surgery. These procedures,
such as percutaneous coronary intervention (PCI) and transcatheter aortic valve
replacement (TAVR), involve smaller incisions and shorter recovery times than
traditional surgical approaches. As these procedures become more common, the
demand for minimally invasive devices is expected to grow which is likely to
augment the growth of Malaysia cardiovascular devices market.” said Mr. Karan
Chechi, Research Director of TechSci Research, a research based global
management consulting firm.
“Malaysia Cardiovascular Devices
Market Segmented By Type (Diagnostic
& Monitoring Devices, Surgical Devices), By Application (Coronary Artery
Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals
& Clinics, Diagnostic Centers, Others), By Source (Import, Domestic), By
Region and Competition, 2020-2030F,” has evaluated the future growth potential of
Malaysia cardiovascular devices market and provides statistics & information
on market size, structure, and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in
Malaysia cardiovascular devices market.
Contact
TechSci Research LLC
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web:
https://www.techsciresearch.com